BRIEF-FDA stresses Boston Scientific anti-stroke device did not meet non-inferiority goal in study

CHICAGO Mon Dec 9, 2013 9:21am EST

CHICAGO Dec 9 (Reuters) - Boston Scientific Corp : * FDA emphasizes Boston Scientific anti-stroke device did not meet

non-inferiority goal in prevail study * FDA says advisory panel for watchman device should consider whether new

safety data address earlier study concerns

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.